AnesthesiaNCT07864402
Patient State Index at Laryngoscopy and Tracheal Intubation Conditions
An observational study of Anesthesia and Intubation, Endotracheal, run by Sakarya University at 1 site in Turkey (Türkiye).
Trial summary
The goal of this observational study is to learn whether the depth of anesthesia at the moment the breathing tube is placed is related to how easily the tube can be placed, in adult women (18 to 65 years) having planned surgery under general anesthesia. Read more about this study
- Who is it for?
- Ages 18 to 65 years, women only
- Conditions the study is for
- Anesthesia, Intubation, Endotracheal, Anesthesia Depth Monitoring
- What is being tested?
- Depth of anesthesia at laryngoscopy (Patient State Index)
- How many people
- 162 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Oct 2026to 1 Oct 2027
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- Women only
- No healthy volunteers
- Adult, Older adult
Study population: Consecutive adult women scheduled for elective surgery under general anesthesia with orotracheal intubation in the study operating room of a single tertiary training and research hospital.
Who may be able to join
- - Female sex
- - Age 18 to 65 years
- - ASA physical status I to III
- - Scheduled for elective surgery under general anesthesia with planned orotracheal intubation
- - Written informed consent
Who cannot join
- - Anticipated difficult intubation (Mallampati class III or IV, thyromental distance less than 6 cm, or a history of difficult intubation)
- - Neuromuscular disease (e.g. myasthenia gravis, Lambert-Eaton syndrome, muscular dystrophy)
- - Chronic opioid use for more than 4 weeks
- - Body mass index greater than 35 kg/m²
- - Known allergy or hypersensitivity to the anesthetic agents to be used
- - Chronic use of antidepressant, antipsychotic or antiepileptic medication for
Show all 11Show fewer
- a neurological or psychiatric disorder
- - Severe cardiovascular disease (ejection fraction below 40%, uncontrolled hypertension, or unstable angina)
- - Hepatic failure (Child-Pugh class B or C)
- - Indication for rapid sequence induction
- - Any condition preventing application of a frontal EEG sensor
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Ayça Taş Tuna, Prof. Dr contact
Turkey (Türkiye)1 site
Sakarya University Training and Research Hospital, Department of Anesthesiology and Reanimation
Sakarya, Adapazari, 54000
Ahmet R Doğan, +905427988070, a.ridvandogan@gmail.com
About this study
Official title: Association Between Depth of Hypnosis Measured by the Patient State Index at Laryngoscopy and the Quality of Tracheal Intubation Conditions: A Prospective Observational Cohort Study
The goal of this observational study is to learn whether the depth of anesthesia at the moment the breathing tube is placed is related to how easily the tube can be placed, in adult women (18 to 65 years) having planned surgery under general anesthesia. Depth of anesthesia is measured with the Patient State Index (PSI), a number from 0 to 100 shown by a brain-activity monitor (SedLine) with a sensor placed on the forehead; lower numbers mean deeper anesthesia.
The main questions it aims to answer are:
Read more
- Is the PSI at the moment of tube placement related to the quality of intubation conditions: how relaxed the jaw is, how open the vocal cords are, and whether the patient coughs or moves?
- Does the PSI tell the anesthesia team something about these conditions beyond what they already know from the anesthetic dose, the timing of the muscle relaxant, and the patient's age?
There is no comparison group; all participants are in one group.
Participants will:
- Receive their usual anesthesia care. The study does not change any drug, dose or timing, and all decisions stay with their anesthesiologist.
- Have their depth of anesthesia and muscle relaxation recorded with monitors that are already part of routine care at this hospital. While the breathing tube is being placed, the brain-activity monitor screen is turned away from the anesthesiologist placing the tube, and a second doctor watches it the whole time.
- Answer a few short questions on the day after surgery about sore throat, hoarseness, and whether they remember anything from the operation.
Read the detailed description
Background. Inadequate hypnotic depth at laryngoscopy may provoke laryngeal reflexes, hemodynamic responses and airway trauma. The 2023 Good Clinical Research Practice (GCRP) guideline recommends that depth of anesthesia at intubation be measured objectively. Previous studies used the bispectral index; the Patient State Index (PSI) has not been studied, and the two indices are not interchangeable.
Design. Single-center, prospective, observational cohort study of consecutive eligible patients in one operating room, where all intubations are performed by the same attending anesthesiologist. Processed-EEG (SedLine) and quantitative neuromuscular monitoring are part of routine care; no additional monitoring is applied.
Routine practice (not mandated by the protocol). Lidocaine 1 mg/kg and fentanyl 1 µg/kg, then propofol target-controlled infusion (Eleveld model, effect-site target 3 µg/mL). When the target is reached, the infusion is stopped and rocuronium 0.6 mg/kg is given; the trachea is intubated by direct laryngoscopy when the train-of-four count reaches zero. The protocol prescribes no drug, dose or timing; the drugs actually given and any deviation are recorded.
Blinding and safety. From induction until intubation conditions have been graded, the SedLine display is turned away from the intubating anesthesiologist. This does not alter care, because the timing of intubation is routinely based on the effect-site target and the train-of-four count, both of which remain visible. An independent observer records the EEG variables, watches the display, and immediately informs the anesthesiologist if PSI exceeds 60 for more than 30 seconds after the neuromuscular blocking agent; all clinical decisions remain with the anesthesiologist. Awareness is assessed on the first postoperative day with a modified Brice questionnaire.
Measurements. T0 = baseline; T1 = neuromuscular blocking agent; T2 = laryngoscope insertion; T3 and T4 = 1 and 3 minutes after intubation. Because the SedLine displays PSI with a delay of about 25 seconds, the PSI at each time point is the median of trend values from 5 seconds before to 25 seconds after the event, which reflects the 30 seconds of EEG preceding it. Participants with a median artifact percentage above 10% in the T2 window are flagged. The intubating anesthesiologist grades the three GCRP/Copenhagen components (ease of laryngoscopy, vocal cord position, reaction to intubation; excellent = 2, good = 1, poor = 0), which are summed into a composite score of 0 to 6; the standard categorical grade is also reported. The independent observer grades the reaction component a second time to assess inter-observer agreement.
Analysis. Proportional odds ordinal logistic regression of the composite score on the PSI at laryngoscopy, adjusted for three pre-specified confounders: predicted propofol effect-site concentration at laryngoscopy, interval from neuromuscular blocking agent to laryngoscopy, and age. The effect measure is the odds ratio per 10-unit increase in PSI with its 95% confidence interval. The question is whether the PSI adds information beyond what the anesthesiologist already knows; the model is associational, not causal. Pre-specified sensitivity analyses exclude, in turn, participants with Cormack-Lehane grade 3-4, a failed first attempt, a safety alert, an additional dose of neuromuscular blocking agent, a train-of-four count above zero, or artifact above 10%. Secondary outcomes are exploratory. Model checks and fallback models are specified in the statistical analysis plan.
Sample size. Power was estimated by simulation for the proportional odds model, allowing for the expected ceiling effect in the composite score and for correlation between the PSI and the confounders. To detect an odds ratio of 0.50 per 10 PSI units with 80% power (two-sided alpha 0.05), under the conservative assumption that 75% of participants reach the maximum score, 145 analyzable participants are required; allowing for 10% loss, 162 participants will be enrolled.
- Being tested
- Depth of anesthesia at laryngoscopy (Patient State Index)
- Keywords
- patient state index, depth of anesthesia, intubation conditions, copenhagen score
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Depth of anesthesia at laryngoscopy (Patient State Index)Other
Exposure of interest, not an assigned intervention. The Patient State Index is measured with routinely used SedLine processed-EEG monitoring at the moment of laryngoscopy. The display is kept out of view of the intubating anesthesiologist until intubation conditions have been graded. No aspect of anesthetic management is directed by the protocol.
| Study group | Role | What they receive |
|---|---|---|
| Adult women undergoing elective general anesthesia with orotracheal intubation | Single cohort. All participants receive routine anesthetic care determined by the attending anesthesiologist, including routine processed-EEG and quantitative neuromuscular monitoring. No group assignment or treatment is made by the protocol. Receives: Other: Depth of anesthesia at laryngoscopy (Patient State Index) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Composite Intubation Condition Score
Composite intubation condition score (range 0-6; higher scores indicate better conditions): the sum of the three Good Clinical Research Practice (GCRP) 2023 components (ease of laryngoscopy, vocal cord position, reaction to intubation), each scored excellent 2, good 1, or poor 0, graded by the intubating anesthesiologist blinded to the Patient State Index (PSI). Analyzed as the odds ratio (95% CI) per 10-unit increase in PSI at laryngoscopy, from a proportional odds ordinal logistic regression adjusted for predicted propofol effect-site concentration, interval from neuromuscular blocking agent to laryngoscopy, and age.
Measured: At laryngoscopy (T2), typically within 10 minutes of the start of induction of anesthesia
Secondary outcomes (6)
Patient State Index in clinically acceptable versus unacceptable intubation conditions
Median PSI at laryngoscopy in participants with clinically acceptable (excellent or good) and unacceptable (poor) overall intubation conditions, with the Hodges-Lehmann median difference and its 95% confidence interval; and the adjusted odds ratio per 10-unit increase in PSI from a binary logistic regression with the same three confounders as the primary model. If fewer than 5 participants have unacceptable conditions, results are reported descriptively only and no model is fitted.
Measured: At laryngoscopy (T2)
Percentage Change in Mean Arterial Pressure at 1 Minute After Intubation
Percentage change in mean arterial pressure (MAP) from baseline to 1 minute after intubation, [(MAP at T3 - MAP at T0) / MAP at T0] x 100, measured non-invasively. Analyzed as the regression coefficient (95% CI) per 10-unit increase in the Patient State Index (PSI) at laryngoscopy, from a multiple linear regression adjusted for the same three confounders as the primary outcome. A positive coefficient is expected, since a higher PSI indicates lighter hypnosis. A sensitivity analysis excludes participants who received remifentanil, a vasoactive drug or an additional anesthetic before T3.
Measured: Baseline (T0), laryngoscopy (T2), and 1 minute after completion of intubation (T3)
Percentage Change in Mean Arterial Pressure at 3 Minutes After Intubation
Percentage change in mean arterial pressure (MAP) from baseline to 3 minutes after intubation, [(MAP at T4 - MAP at T0) / MAP at T0] x 100, measured non-invasively. Analyzed as the regression coefficient (95% CI) per 10-unit increase in the Patient State Index (PSI) at laryngoscopy, from a multiple linear regression adjusted for the same three confounders as the primary outcome. A positive coefficient is expected, since a higher PSI indicates lighter hypnosis. A sensitivity analysis excludes participants who received remifentanil, a vasoactive drug or an additional anesthetic before T4.
Measured: Baseline (T0), laryngoscopy (T2), and 3 minutes after completion of intubation (T4)
Change in Patient State Index From Neuromuscular Blocking Agent Administration to Laryngoscopy
Within-participant change in the Patient State Index (PSI; SedLine processed-EEG index, range 0-100; lower values indicate deeper hypnosis) from administration of the neuromuscular blocking agent (T1) to laryngoscopy (T2), tested with the Wilcoxon signed-rank test. Descriptive only: there is no comparison group without neuromuscular blockade, and the propofol infusion is stopped at T1 so its effect-site concentration changes over the same interval; the change therefore cannot be attributed to electromyographic suppression.
Measured: Administration of the neuromuscular blocking agent (T1) to laryngoscopy (T2), up to 15 minutes
Change in SedLine Electromyography (EMG) Index From Neuromuscular Blocking Agent Administration to Laryngoscopy
Within-participant change in the SedLine electromyography (EMG) index (range 0-100%; higher values indicate more facial muscle activity) from administration of the neuromuscular blocking agent (T1) to laryngoscopy (T2), tested with the Wilcoxon signed-rank test. Descriptive only: there is no comparison group without neuromuscular blockade.
Measured: Administration of the neuromuscular blocking agent (T1) to laryngoscopy (T2), up to 15 minutes
Number of Participants With Sore Throat or Hoarseness on the First Postoperative Day
Number (%) of participants with sore throat or hoarseness (either symptom) on structured inquiry on the first postoperative day. Analyzed as the odds ratio (95% CI) per 1-point increase in the composite intubation condition score (range 0-6; higher scores indicate better conditions), from a logistic regression.
Measured: First postoperative day (approximately 24 hours after surgery)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Oct 2026
- Study start1 Oct 2026 (estimated)
- Primary completion1 Apr 2027 (estimated)
- Study completion1 Oct 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AnesthesiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 162 participants (estimated)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Sakarya University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ayça Taş Tuna, Sakarya University
- Investigators
- Ayca Tas Tuna, Professor, M.D., Principal investigator, Sakarya University Faculty of Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07864402
- Sponsor's protocol ID
- SEAH-IntQuality
- Status last verified
- Oct 2026
- First submitted
- 23 Sep 2026
- Last updated
- 22 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: De-identified individual participant data underlying the published results will be made available to qualified researchers upon reasonable request to the corresponding author, subject to approval of a methodologically sound proposal and a data sharing agreement.
Study at a glance
From the registry record, last updated by the sponsor on 22 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Association Between Depth of Hypnosis Measured by the Patient State Index at Laryngoscopy and the Quality of Tracheal Intubation Conditions: A Prospective Observational Cohort Study
- ClinicalTrials.gov ID
- NCT07864402
- Acronym / sponsor ID
- SEAH-IntQuality
- Keywords
- patient state index, depth of anesthesia, intubation conditions, copenhagen score
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 162 participants (estimated)
- Lead sponsor
- Sakarya UniversityUniversity, hospital or other
- Study start
- 1 Oct 2026 (estimated)
- Primary completion
- 1 Apr 2027 (estimated)
- Study completion
- 1 Oct 2027 (estimated)
- First posted
- 7 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational study is to learn whether the depth of anesthesia at the moment the breathing tube is placed is related to how easily the tube can be placed, in adult women (18 to 65 years) having planned surgery under general anesthesia. Depth of anesthesia is measured with the Patient State Index (PSI), a number from 0 to 100 shown by a brain-activity monitor (SedLine) with a sensor placed on the forehead; lower numbers mean deeper anesthesia.
The main questions it aims to answer are:
- Is the PSI at the moment of tube placement related to the quality of intubation conditions: how relaxed the jaw is, how open the vocal cords are, and whether the patient coughs or moves?
- Does the PSI tell the anesthesia team something about these conditions beyond what they already know from the anesthetic dose, the timing of the muscle relaxant, and the patient's age?
There is no comparison group; all participants are in one group.
Participants will:
- Receive their usual anesthesia care. The study does not change any drug, dose or timing, and all decisions stay with their anesthesiologist.
- Have their depth of anesthesia and muscle relaxation recorded with monitors that are already part of routine care at this hospital. While the breathing tube is being placed, the brain-activity monitor screen is turned away from the anesthesiologist placing the tube, and a second doctor watches it the whole time.
- Answer a few short questions on the day after surgery about sore throat, hoarseness, and whether they remember anything from the operation.
Detailed description
Background. Inadequate hypnotic depth at laryngoscopy may provoke laryngeal reflexes, hemodynamic responses and airway trauma. The 2023 Good Clinical Research Practice (GCRP) guideline recommends that depth of anesthesia at intubation be measured objectively. Previous studies used the bispectral index; the Patient State Index (PSI) has not been studied, and the two indices are not interchangeable.
Design. Single-center, prospective, observational cohort study of consecutive eligible patients in one operating room, where all intubations are performed by the same attending anesthesiologist. Processed-EEG (SedLine) and quantitative neuromuscular monitoring are part of routine care; no additional monitoring is applied.
Routine practice (not mandated by the protocol). Lidocaine 1 mg/kg and fentanyl 1 µg/kg, then propofol target-controlled infusion (Eleveld model, effect-site target 3 µg/mL). When the target is reached, the infusion is stopped and rocuronium 0.6 mg/kg is given; the trachea is intubated by direct laryngoscopy when the train-of-four count reaches zero. The protocol prescribes no drug, dose or timing; the drugs actually given and any deviation are recorded.
Blinding and safety. From induction until intubation conditions have been graded, the SedLine display is turned away from the intubating anesthesiologist. This does not alter care, because the timing of intubation is routinely based on the effect-site target and the train-of-four count, both of which remain visible. An independent observer records the EEG variables, watches the display, and immediately informs the anesthesiologist if PSI exceeds 60 for more than 30 seconds after the neuromuscular blocking agent; all clinical decisions remain with the anesthesiologist. Awareness is assessed on the first postoperative day with a modified Brice questionnaire.
Measurements. T0 = baseline; T1 = neuromuscular blocking agent; T2 = laryngoscope insertion; T3 and T4 = 1 and 3 minutes after intubation. Because the SedLine displays PSI with a delay of about 25 seconds, the PSI at each time point is the median of trend values from 5 seconds before to 25 seconds after the event, which reflects the 30 seconds of EEG preceding it. Participants with a median artifact percentage above 10% in the T2 window are flagged. The intubating anesthesiologist grades the three GCRP/Copenhagen components (ease of laryngoscopy, vocal cord position, reaction to intubation; excellent = 2, good = 1, poor = 0), which are summed into a composite score of 0 to 6; the standard categorical grade is also reported. The independent observer grades the reaction component a second time to assess inter-observer agreement.
Analysis. Proportional odds ordinal logistic regression of the composite score on the PSI at laryngoscopy, adjusted for three pre-specified confounders: predicted propofol effect-site concentration at laryngoscopy, interval from neuromuscular blocking agent to laryngoscopy, and age. The effect measure is the odds ratio per 10-unit increase in PSI with its 95% confidence interval. The question is whether the PSI adds information beyond what the anesthesiologist already knows; the model is associational, not causal. Pre-specified sensitivity analyses exclude, in turn, participants with Cormack-Lehane grade 3-4, a failed first attempt, a safety alert, an additional dose of neuromuscular blocking agent, a train-of-four count above zero, or artifact above 10%. Secondary outcomes are exploratory. Model checks and fallback models are specified in the statistical analysis plan.
Sample size. Power was estimated by simulation for the proportional odds model, allowing for the expected ceiling effect in the composite score and for correlation between the PSI and the confounders. To detect an odds ratio of 0.50 per 10 PSI units with 80% power (two-sided alpha 0.05), under the conservative assumption that 75% of participants reach the maximum score, 145 analyzable participants are required; allowing for 10% loss, 162 participants will be enrolled.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 1 Day
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Adult women undergoing elective general anesthesia with orotracheal intubation | – | Other: Depth of anesthesia at laryngoscopy (Patient State Index)Single cohort. All participants receive routine anesthetic care determined by the attending anesthesiologist, including routine processed-EEG and quantitative neuromuscular monitoring. No group assignment or treatment is made by the protocol. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Consecutive adult women scheduled for elective surgery under general anesthesia with orotracheal intubation in the study operating room of a single tertiary training and research hospital.
Key inclusion criteria (5 listed)
- - Female sex
- - Age 18 to 65 years
- - ASA physical status I to III
- - Scheduled for elective surgery under general anesthesia with planned orotracheal intubation
- - Written informed consent
Key exclusion criteria (11 listed)
- - Anticipated difficult intubation (Mallampati class III or IV, thyromental distance less than 6 cm, or a history of difficult intubation)
- - Neuromuscular disease (e.g. myasthenia gravis, Lambert-Eaton syndrome, muscular dystrophy)
- - Chronic opioid use for more than 4 weeks
- - Body mass index greater than 35 kg/m²
- - Known allergy or hypersensitivity to the anesthetic agents to be used
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Depth of anesthesia at laryngoscopy (Patient State Index)Exposure of interest, not an assigned intervention. The Patient State Index is measured with routinely used SedLine processed-EEG monitoring at the moment of laryngoscopy. The display is kept out of view of the intubating anesthesiologist until intubation conditions have been graded. No aspect of anesthetic management is directed by the protocol. | Other | Adult women undergoing elective general anesthesia with orotracheal intubation |
Primary outcome
Composite Intubation Condition Score
Time frame: At laryngoscopy (T2), typically within 10 minutes of the start of induction of anesthesia
Composite intubation condition score (range 0-6; higher scores indicate better conditions): the sum of the three Good Clinical Research Practice (GCRP) 2023 components (ease of laryngoscopy, vocal cord position, reaction to intubation), each scored excellent 2, good 1, or poor 0, graded by the intubating anesthesiologist blinded to the Patient State Index (PSI). Analyzed as the odds ratio (95% CI) per 10-unit increase in PSI at laryngoscopy, from a proportional odds ordinal logistic regression adjusted for predicted propofol effect-site concentration, interval from neuromuscular blocking agent to laryngoscopy, and age.
6 secondary outcomes
Patient State Index in clinically acceptable versus unacceptable intubation conditions
Time frame: At laryngoscopy (T2)
Percentage Change in Mean Arterial Pressure at 1 Minute After Intubation
Time frame: Baseline (T0), laryngoscopy (T2), and 1 minute after completion of intubation (T3)
Percentage Change in Mean Arterial Pressure at 3 Minutes After Intubation
Time frame: Baseline (T0), laryngoscopy (T2), and 3 minutes after completion of intubation (T4)
Change in Patient State Index From Neuromuscular Blocking Agent Administration to Laryngoscopy
Time frame: Administration of the neuromuscular blocking agent (T1) to laryngoscopy (T2), up to 15 minutes
Change in SedLine Electromyography (EMG) Index From Neuromuscular Blocking Agent Administration to Laryngoscopy
Time frame: Administration of the neuromuscular blocking agent (T1) to laryngoscopy (T2), up to 15 minutes
Number of Participants With Sore Throat or Hoarseness on the First Postoperative Day
Time frame: First postoperative day (approximately 24 hours after surgery)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Oct 2026.
- Individual participant dataSharing planned: Yes. De-identified individual participant data underlying the published results will be made available to qualified researchers upon reasonable request to the corresponding author, subject to approval of a methodologically sound proposal and a data sharing agreement.
Related trials for Anesthesia
Recruiting
Platelet-Rich Fibrin in Revision Cartilage Tympanoplasty
Tympanic Membrane Perforation, Chronic Otitis Media
Not yet recruitingPhase 4
Effect of Neuromuscular Blocking Agent Use on Video Laryngeal Mask Airway Insertion
Airway Management, Supraglottic Airway Device Insertion
Active, not recruitingObservational study
Dexmedetomidine Nasal Spray and Postoperative Sore Throat After Bronchoscopy
Postoperative Sore Throat, Bronchoscopy
Recruiting
Buzzy Bee for Pain and Anxiety Control During Pediatric Dental Local Anesthesia
Anesthesia, Anxiety
Recruiting
Conscious Sedation Versus General Anesthesia for Pulsed Field Ablation in Paroxysmal Atrial Fibrillation
Paroxysmal Atrial Fibrillation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Ayça Taş Tuna, Prof. Dr contact
Ayca Tas Tuna, Professor, M.D. principal investigator
Sakarya University Faculty of Medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Anesthesia and Intubation, Endotracheal, run by Sakarya University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 22 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact AHMET R DOĞAN (+905427988070, a.ridvandogan@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Composite Intubation Condition Score (time frame: At laryngoscopy (T2), typically within 10 minutes of the start of induction of anesthesia). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2026.